Watch and understand
VideosTEACHING RESOURCE M0017
IBD: infection assessment and prevention
A 2020 FMC-HGE lecture on infection-related assessment for immunosuppressants and biologics in IBD.
FMC-HGE · 2020
Free MICA accountOpen
MICA
Therapeutic safety and prioritisation
A GUIDED SELECTION
Four videos for discussing infection prevention, methotrexate safety and assessment of urgent presentations.
Learning objectives
- Identify the context and scope of each safety message.
- Explain a priority using the case’s warning signs.
01
Observe
Describe the document or recording before looking at the explanation.
02
Compare
Use the teaching notes and original source to revisit your interpretation.
03
Apply
Return to the course, book or OSCE station associated with the resource.
Watch and understand
Videos · 0:50TEACHING RESOURCE M0018
Oral methotrexate: preventing dosing-frequency errors
An ANSM safety message on weekly oral methotrexate dosing for inflammatory diseases.
ANSM
Free MICA accountOpen
Watch and understand
Videos · 10:39TEACHING RESOURCE M0019
Adrenal insufficiency: diagnosis and initial management
A CeMIR video from the acute adrenal insufficiency chapter, accompanying the prioritisation workshop.
CeMIR Learning
Free MICA accountOpen
Watch and understand
Videos · 16:12TEACHING RESOURCE M0020
Giant cell arteritis: the Fast Track pathway
A FAI²R interview on organising a rapid diagnostic pathway for giant cell arteritis.
FAI²R
Free MICA accountOpen
ImagesMICA IMAGES A0094
Immunotherapy: make the treatment decision safer
A safety pathway replaces commercial medication photographs. It does not assign one product to every patient with a disease.
MICA · schéma original du 15 octobre 2026 ; aucune image tierce incorporée
Open accessOpen
ImagesMICA IMAGES A0098
MAS: recognise a concerning trajectory
The diagram emphasises the clinical and laboratory trajectory rather than one isolated threshold. It shows no calculated probability or fictitious score.
MICA · schéma original du 15 octobre 2026 ; aucune image tierce incorporée
Open accessOpen